Brain-implant adapts brain stimulation to ease Parkinson’s tremors

An adaptive deep brain stimulation (aDBS) device—essentially a brain pacemaker that adjusts electrical pulses in real time—has begun to transform Parkinson’s care. After FDA approval in 2025, the implant, tested in international trials, is designed to tailor stimulation to brain activity, reducing tremors and medication side effects for some patients while not offering a cure. The first patient in the pivotal study reported dramatic tremor relief and cognitive improvements, signaling a promising new frontier in personalized neurotherapy.